Information on upcoming events hosted by the Institute of Health Economics (IHE) as well as upcoming events hosted by national and international health economics organizations and associations.
The IHE serves as a neutral convenor for health policy dialogue and evidence development and dissemination. The format for each event is tailored to suit the topic, purpose, and audience. Below is information on upcoming events hosted by the Institute of Health Economics (IHE) as well as upcoming events hosted by national and international health economics organizations and associations.
For all information relating to our past events including videos, presentations, conference programs, and more, click HERE!
Presented by NOAHE and Alberta RWE. Dr. Scott Klarenbach will be speaking about the importance of Real World Evidence (RWE), how the province of Alberta has advantages with respect to utilizing Real World Evidence to facilitate cutting edge research and development, and how the Alberta RWE Consortium will help the province become a global leader in Real World Evidence generation.
Analytic work at Alberta Health can be stratified into three classes: Descriptive, Predictive, and Prescriptive. The Advanced Analytics team uses all analytic levels to best inform decision makers. This session will begin with an overview of Alberta Health data assets, discussing how these are leveraged through linkage and transformation. Next, examples of how administrative data can be used for predictive and prescriptive modelling will be introduced, with a focus on health economic evaluations. Finally, issues around performance of inputs and parameters from administrative data will be discussed, with implications for best practice.
The HTAi Global Policy Forum provides a unique opportunity for senior representatives from public and private sector organizations using HTA to support decisions or recommendations about product development and coverage to meet one another, members of the HTAi Board and invited international experts, for strategic discussions about the present state of HTA, its development and its implications for health care systems, industry, patients and other stakeholders.